About Manus Neuro
Manus Neuro is a company based in Motherwell (United Kingdom) founded in 2008 by Rutger Zietsma. Manus Neuro has raised $5.79 million across 5 funding rounds from investors including Scottish Enterprise, North East Fund and Par Equity. The company has 6 employees as of June 30, 2020. Manus Neuro offers products and services including NeuroMotor Pen and NeuroMotor Pen App. Manus Neuro operates in a competitive market with competitors including Luciole Medical, CND Life Sciences, PD Neurotechnology, NeuroKaire and Rhaeos, among others.
- Headquarter Motherwell, United Kingdom
- Employees 6 as on 30 Jun, 2020
- Founders Rutger Zietsma
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Manus Neurodynamica Ltd
- Date of Incorporation 14 Aug, 2008
- Jurisdiction NORTH SHIELDS, TYNE AND WEAR
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5.79 M (USD)
in 5 rounds
-
Latest Funding Round
$3.22 M (USD), Series A
May 25, 2023
-
Investors
Scottish Enterprise
& 7 more
-
Employee Count
6
as on Jun 30, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Manus Neuro
Manus Neuro offers a comprehensive portfolio of products and services, including NeuroMotor Pen and NeuroMotor Pen App.
Assesses fine motor skills to aid in diagnosing neuromotor disorders like Parkinson's.
Analyzes data from device for clinical monitoring and differential diagnosis.
People of Manus Neuro
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Manus Neuro
Manus Neuro has successfully raised a total of $5.79M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $3.22 million completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Manus Neuro
Manus Neuro has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Scottish Enterprise, North East Fund and Par Equity.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment finance is provided to small and medium-sized enterprises.
|
Locked | Locked | Locked | |
|
Venture capital and natural capital investments are managed by Par Equity.
|
Locked | Locked | Locked | |
|
Venture capital fund focused on social impact companies
|
Locked | Locked | Locked |
Investor details for Manus Neuro
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Manus Neuro
Investment portfolio details for Manus Neuro
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Manus Neuro
Detailed financials for Manus Neuro
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Manus Neuro Comparisons
Peer comparison for Manus Neuro
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Manus Neuro
Manus Neuro operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Luciole Medical, CND Life Sciences, PD Neurotechnology, NeuroKaire and Rhaeos, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Brain monitoring devices and analytics platforms are developed and provided.
|
|
| Locked | Locked | Locked |
Provider of a neurological disease diagnostic tool for providers
|
|
| Locked | Locked | Locked |
A wearable device is developed to monitor Parkinson's movement disorders.
|
|
| Locked | Locked | Locked |
Platform offering personalized treatment for psychiatric and neurological conditions
|
|
| Locked | Locked | Locked |
Noninvasive device developed for CSF monitoring and hydrocephalus management.
|
Detailed competitors of Manus Neuro
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Manus Neuro
Complete news archive for Manus Neuro
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manus Neuro
Manus Neuro was founded in 2008 and raised its 1st funding round 10 years after it was founded.
Manus Neuro is headquartered in Motherwell, United Kingdom. It is registered at Motherwell, Scotland, United Kingdom.
Rutger Zietsma is the current CEO of Manus Neuro. They have also founded this company.
Manus Neuro is a funded company, having raised a total of $5.79M across 5 funding rounds to date.
As of Jun 30, 2020, the latest employee count at Manus Neuro is 6.
Manus Neuro was founded in 2008 and is based in Motherwell, United Kingdom. Devices for identifying biomarkers of neuromotor impairments are offered by the company, supporting screening, rehabilitation, drug development, and medicine optimization. Referrals are streamlined, and costs for specialist services are reduced through these tools. A digital sensor pen has been developed for handwriting assessment, aiding diagnosis and monitoring of Parkinsons disease in clinical settings.
Manus Neuro's top competitors include CND Life Sciences, NeuroKaire and Seer.
Manus Neuro offers NeuroMotor Pen and NeuroMotor Pen App.
Manus Neuro has 8 investors. Key investors include Scottish Enterprise, North East Fund, Par Equity, SIS Ventures, and Old College Capital.